Relay Therapeutics RLAY
NASDAQ RLAY
$18.27 -0.18 (-0.95%)
As of: Oct 21, 2026 · 3:13 PM EDT

Relay Therapeutics (RLAY) Other financing activities (2020)

Updated

Relay Therapeutics' Other financing activities was $1.2 million in FY2021.

Analysis

Relay Therapeutics (RLAY) Other financing activities (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.62 Bn 1,105.21 Bn 19.71 Bn
2 Johnson & Johnson 617.59 Bn 536.12 Bn 17.26 Bn
3 AbbVie 501.69 Bn 474.80 Bn 12.70 Bn
4 Merck 368.29 Bn 322.67 Bn 12.21 Bn
5 Novartis Ag 297.79 Bn 261.78 Bn 11.24 Bn
6 Astrazeneca 260.82 Bn 234.50 Bn 12.86 Bn
7 Amgen 236.53 Bn 191.93 Bn 7.24 Bn
8 Gilead Sciences 191.14 Bn 165.33 Bn 6.22 Bn
9 Pfizer 169.69 Bn 116.33 Bn 10.94 Bn
10 Relay Therapeutics 3.69 Bn 3.19 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -2.05 Mn
API Access

Relay Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=RLAY&period=max&api_key=YOUR_API_KEY